Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sukru Dilege

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Clinical Lung Cancer|July 7, 2011
Induction chemotherapy with triweekly docetaxel and cisplatin followed by concomitant chemoradiotherapy with or without surgery in stage III non-small-cell lung cancer: a phase II studyAdnan Aydiner, Fatma Sen, Esra Kaytan Saglam, et al.
Clinical Nuclear Medicine|August 2, 2007
The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is highCuneyt Turkmen, Kerim Sonmezoglu, Alper Toker, et al.
Surgery Today|March 24, 2006
Hyperhomocysteinemia in patients with arterial occlusive diseaseMurat Aksoy, Yilmaz Basar, Nihal Salmayenli, et al.
Lung Cancer (Amsterdam, Netherlands)|August 9, 2007
Gemcitabine and cisplatin as neo-adjuvant chemotherapy for non-small cell lung cancer: a phase II studyAdnan Aydiner, Murat Kiyik, Saadettin Cikrikcioglu, et al.
Cancer Chemotherapy and Pharmacology|April 19, 2011
Weekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancerFatma Sen, Esra Kaytan Saglam, Alper Toker, et al.
Medical Oncology (Northwood, London, England)|November 8, 2011
Association of clinical and pathological variables with survival in thymomaAdnan Aydiner, Alper Toker, Fatma Sen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 31, 2009
Surgical treatment and prognosis of primitive neuroectodermal tumors of the thoraxAdalet Demir, Mehmet Zeki Gunluoglu, Nergiz Dagoglu, et al.
Journal of Clinical Pharmacy and Therapeutics|November 29, 2019
Elevation in serum uric acid levels predicts favourable response to erlotinib treatment in patients with metastatic non-small-cell lung cancerFatih Selcukbiricik, Elif Ozdogan, Tuncay Dagel, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 21, 2018
Hyperthermic intraperitonal chemotherapy is an independent risk factor for development of acute kidney injuryTuncay Dagel, Selim Misirlioglu, Serhan Tanju, et al.
Clinical Lung Cancer|April 26, 2026
Real-World Clinical Outcomes of Concurrent Chemotherapy and Dose-Escalated Twice-Daily Radiotherapy With Simultaneous Integrated Boost (SIB) for Limited-Stage Small Cell Lung CancerSukran Celikarslan, Duygu Sezen, Merve Duman, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Clinical Lung Cancer|July 7, 2011
Induction chemotherapy with triweekly docetaxel and cisplatin followed by concomitant chemoradiotherapy with or without surgery in stage III non-small-cell lung cancer: a phase II studyAdnan Aydiner, Fatma Sen, Esra Kaytan Saglam, et al.
Clinical Nuclear Medicine|August 2, 2007
The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is highCuneyt Turkmen, Kerim Sonmezoglu, Alper Toker, et al.
Surgery Today|March 24, 2006
Hyperhomocysteinemia in patients with arterial occlusive diseaseMurat Aksoy, Yilmaz Basar, Nihal Salmayenli, et al.
Lung Cancer (Amsterdam, Netherlands)|August 9, 2007
Gemcitabine and cisplatin as neo-adjuvant chemotherapy for non-small cell lung cancer: a phase II studyAdnan Aydiner, Murat Kiyik, Saadettin Cikrikcioglu, et al.
Cancer Chemotherapy and Pharmacology|April 19, 2011
Weekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancerFatma Sen, Esra Kaytan Saglam, Alper Toker, et al.
Medical Oncology (Northwood, London, England)|November 8, 2011
Association of clinical and pathological variables with survival in thymomaAdnan Aydiner, Alper Toker, Fatma Sen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 31, 2009
Surgical treatment and prognosis of primitive neuroectodermal tumors of the thoraxAdalet Demir, Mehmet Zeki Gunluoglu, Nergiz Dagoglu, et al.
Journal of Clinical Pharmacy and Therapeutics|November 29, 2019
Elevation in serum uric acid levels predicts favourable response to erlotinib treatment in patients with metastatic non-small-cell lung cancerFatih Selcukbiricik, Elif Ozdogan, Tuncay Dagel, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 21, 2018
Hyperthermic intraperitonal chemotherapy is an independent risk factor for development of acute kidney injuryTuncay Dagel, Selim Misirlioglu, Serhan Tanju, et al.
Clinical Lung Cancer|April 26, 2026
Real-World Clinical Outcomes of Concurrent Chemotherapy and Dose-Escalated Twice-Daily Radiotherapy With Simultaneous Integrated Boost (SIB) for Limited-Stage Small Cell Lung CancerSukran Celikarslan, Duygu Sezen, Merve Duman, et al.
Pageof 4